The stock of Insmed Inc (INSM) has gone down by -3.18% for the week, with a -4.17% drop in the past month and a -17.75% drop in the past quarter. The volatility ratio for the week is 4.34%, and the volatility levels for the past 30 days are 3.95% for INSM. The simple moving average for the past 20 days is -5.81% for INSM’s stock, with a -10.58% simple moving average for the past 200 days.
Is It Worth Investing in Insmed Inc (NASDAQ: INSM) Right Now?
The 36-month beta value for INSM is also noteworthy at 0.80. There are mixed opinions on the stock, with 12 analysts rating it as a “buy,” 6 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for INSM is 178.38M, and at present, short sellers hold a 8.85% of that float. The average trading volume of INSM on May 14, 2025 was 2.25M shares.
INSM) stock’s latest price update
Insmed Inc (NASDAQ: INSM) has seen a decline in its stock price by -3.01 in relation to its previous close of 67.75. However, the company has experienced a -3.18% decline in its stock price over the last five trading sessions. zacks.com reported 2025-05-13 that Examine the evolution of Insmed’s (INSM) overseas revenue trends and their effects on Wall Street’s forecasts and the stock’s prospects.
Analysts’ Opinion of INSM
RBC Capital Mkts, on the other hand, stated in their research note that they expect to see INSM reach a price target of $100. The rating they have provided for INSM stocks is “Outperform” according to the report published on February 25th, 2025.
Truist gave a rating of “Buy” to INSM, setting the target price at $48 in the report published on April 23rd of the previous year.
INSM Trading at -9.34% from the 50-Day Moving Average
After a stumble in the market that brought INSM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -22.61% of loss for the given period.
Volatility was left at 3.95%, however, over the last 30 days, the volatility rate increased by 4.34%, as shares sank -7.49% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -13.87% lower at present.
During the last 5 trading sessions, INSM fell by -3.18%, which changed the moving average for the period of 200-days by -11.80% in comparison to the 20-day moving average, which settled at $69.76. In addition, Insmed Inc saw -4.82% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at INSM starting from Lewis William, who proposed sale 17,442 shares at the price of $67.81 back on May 13 ’25. After this action, Lewis William now owns shares of Insmed Inc, valued at $1,182,742 using the latest closing price.
Bonstein Sara, the Officer of Insmed Inc, proposed sale 8,870 shares at $67.81 during a trade that took place back on May 13 ’25, which means that Bonstein Sara is holding shares at $601,474 based on the most recent closing price.
Stock Fundamentals for INSM
Current profitability levels for the company are sitting at:
- -2.3 for the present operating margin
- 0.76 for the gross margin
The net margin for Insmed Inc stands at -2.66. The total capital return value is set at -0.56. Equity return is now at value -890.75, with -68.42 for asset returns.
Based on Insmed Inc (INSM), the company’s capital structure generated 0.92 points at debt to capital in total, while cash flow to debt ratio is standing at -0.67. The debt to equity ratio resting at 11.53. The interest coverage ratio of the stock is -10.72.
Currently, EBITDA for the company is -814.14 million with net debt to EBITDA at -0.8. When we switch over and look at the enterprise to sales, we see a ratio of 33.35. The receivables turnover for the company is 7.98for trailing twelve months and the total asset turnover is 0.21. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.86.
Conclusion
In summary, Insmed Inc (INSM) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
